Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Integrated BioPharma, Inc. market cap is $6.47M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Integrated BioPharma, Inc. 52 week high is $0.38 as of April 27, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Integrated BioPharma, Inc. 52 week low is $0.17 as of April 27, 2024.
Integrated BioPharma, Inc. stock price today is $0.215.
Integrated BioPharma, Inc. stock price yesterday was $0.22.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Integrated BioPharma, Inc.’s P/E ratio is -16.80.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Integrated BioPharma, Inc. P/B ratio is 0.3486.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Integrated BioPharma, Inc.'s EBITDA is 10.93.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Integrated BioPharma, Inc. 50-day moving average is $0.2212.
Integrated BioPharma, Inc. has 141 employees.